Belite Bio Income Statement (2021-2026) | BLTE

Income Statement Dec2021 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating items
Research & Development (Quarter) 1.58B1.19B0.01B5.72B5.52B0.01B0.00B6.76B9.08B6.84B7.25B0.01B11.05B10.31B14.62B0.02B
Selling, General & Administrative (Quarter) 0.93B1.35B0.00B1.16B1.35B0.00B0.00B1.56B1.39B2.90B4.20B0.01B6.55B12.71B13.45B0.02B
Operating Expenses (Quarter) 2.51B2.54B0.01B6.88B6.87B0.01B0.01B8.33B10.47B9.74B11.46B0.02B17.60B23.02B28.08B0.03B
Operating Income (Quarter) -2.51B-2.54B-0.01B-6.88B-6.87B-0.01B-0.01B-8.33B-10.47B-0.00B-0.00B-15517.00B-17.60B-0.00B-0.00B-0.03B
EBIT (Quarter) -2.51B-2.54B-0.01B-6.88B-6.87B-0.01B-0.01B-8.33B-10.47B-0.00B-0.00B-15517.00B-17.60B-0.00B-0.00B-0.03B
Non-operating items
Other Non Operating Income (Quarter) -0.00B-0.01B-0.01B-0.01B
Non Operating Income (Quarter) 0.12B0.14B-0.00B-0.01B0.06B0.00B-0.00B0.46B0.98B1.06B1.36B0.00B1.28B1.33B2.75B0.01B
Net income details
EBT (Quarter) -2.39B-2.40B-0.01B-6.89B-6.81B-0.01B-0.01B-7.87B-9.49B-8.68B-10.10B-0.01B-16.32B-21.69B-25.32B-0.03B
Tax Provisions (Quarter) 0.01B0.00B0.00B-0.00B0.01B-0.01B
Profit After Tax (Quarter) -2.39B-2.40B-0.01B-6.89B-6.81B-0.01B-0.01B-7.87B-9.49B-8.68B-10.10B-0.01B-16.32B-21.69B-25.32B-0.03B
Income from Continuing Operations (Quarter) -2.39B-2.40B-0.01B-6.89B-6.81B-0.01B-0.01B-7.87B-9.49B-8.67B-10.10B-0.01B-16.32B-21.69B-25.32B-0.03B
Consolidated Net Income (Quarter) -2.39B-2.40B-0.01B-6.89B-6.81B-0.01B-0.01B-7.87B-9.49B-8.67B-10.10B-0.01B-16.32B-21.69B-25.32B-0.03B
Income towards Parent Company (Quarter) -2.39B-2.40B-0.01B-6.89B-6.81B-0.01B-0.01B-7.87B-9.49B-8.67B-10.10B-0.01B-16.32B-21.69B-25.32B-0.03B
Net Income towards Common Stockholders (Quarter) 0.120.100.270.33-0.260.40-0.250.27-0.310.280.320.45-0.500.650.70-0.68
Additional items
EPS (Basic) (Quarter) 0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
EPS (Diluted) (Quarter) 0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Shares Outstanding (Quarter) 0.01B0.01B0.02B0.02B0.02B0.03B0.03B0.03B0.03B0.03B0.03B0.03B0.03B0.03B0.03B0.03B0.40B
Shares Outstanding (Diluted) (Quarter) 0.01B0.01B0.02B0.02B0.02B0.03B0.03B0.03B0.03B0.03B860.000.03B0.03B0.03B0.00B0.03B680.00
EBITDA (Quarter) -2.51B-2.54B-0.01B-6.88B-6.87B-0.01B-0.01B-8.33B-10.47B-0.00B-0.00B-15517.00B-17.60B-0.00B-0.00B-0.03B
Interest Expenses (Quarter) 0.00B0.01B0.00B0.00B0.36B
Tax Rate (Quarter) -0.09-0.04-0.010.01-0.080.07